[January 29, 2015]

Research and Markets: Hemophilia A Pipeline Insights Report 2015

Research and Markets (http://www.researchandmarkets.com/research/6g6wfw/hemophilia) has announced the addition of the "Hemophilia A-Pipeline Insights, 2015" subscription to their offering.

This Hemophilia A-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hemophilia A.

This report provides information on the therapeutic development based on the Hemophilia A dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Precinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

1. Hemophilia A Overview
2. Hemophilia A Pipeline Therapeutics
3. Hemophilia A Therapeutics under Development by Companies
4. Hemophilia A Late Stage Products (Filed and Phase III)
5. Comparative Analysis
6. Hemophilia A Mid Clinical Stage Products (Phase II)
7. Comparative Analysis
8. Hemophilia A Early Clinical Stage Products (Phase I and IND Filed)
9. Comparative Analysis
10. Hemophilia A Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Hemophilia A - Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Hemophilia A - Discontinued Products
19. Hemophilia A - Dormant Products
20. Companies Involved in Therapeutics Development for Hemophilia A
21. Appendix

For more information visit http://www.researchandmarkets.com/research/6g6wfw/hemophilia

[ Back To TMCnet.com's Homepage ]